Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis - Test2 - elhamkhani - TriplyDB

Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis

Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis

http://www.wikidata.org/entity/Q30496706

about

Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis Tuberculosis drug discovery in the post-post-genomic era Genomic and transcriptomic analysis of the streptomycin-dependent Mycobacterium tuberculosis strain 18b.Towards a new tuberculosis drug: pyridomycin - nature's isoniazid The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis.TB drug development: immunology at the table In vitro and in vivo activities of ruthenium(II) phosphine/diimine/picolinate complexes (SCAR) against Mycobacterium tuberculosis In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis.Multitarget drug discovery for tuberculosis and other infectious diseases.A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis Potassium availability triggers Mycobacterium tuberculosis transition to, and resuscitation from, non-culturable (dormant) states.Novel imidazoline antimicrobial scaffold that inhibits DNA replication with activity against mycobacteria and drug resistant Gram-positive cocci Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis.Detection of inhibitors of phenotypically drug-tolerant Mycobacterium tuberculosis using an in vitro bactericidal screen.Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model Discovery of a capuramycin analog that kills nonreplicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG Dormant non-culturable Mycobacterium tuberculosis retains stable low-abundant mRNA.Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis.Current and novel approaches to vaccine development against tuberculosis.CD271(+) bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis.In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis.Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis.The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?Antimicrobial treatment improves mycobacterial survival in nonpermissive growth conditions.Mechanism of action of 5-nitrothiophenes against Mycobacterium tuberculosis.Tuberculosis drugs: new candidates and how to find more.A review of murine models of latent tuberculosis infection.Targeting persisters for tuberculosis control Navigating tuberculosis drug discovery with target-based screening.The normalcy of dormancy: common themes in microbial quiescence Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis.Assessing the essentiality of the decaprenyl-phospho-d-arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants.Targeting Phenotypically Tolerant Mycobacterium tuberculosis.Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria.Development of an In Vitro Assay for Detection of Drug-Induced Resuscitation-Promoting-Factor-Dependent Mycobacteria.Current challenges in drug discovery for tuberculosis.Synthesis of new generation triazolyl- and isoxazolyl-containing 6-nitro-2,3-dihydroimidazooxazoles as anti-TB agents: in vitro, structure-activity relationship, pharmacokinetics and in vivo evaluation.In vitro combination studies of benzothiazinone lead compound BTZ043 against Mycobacterium tuberculosis New 2-thiopyridines as potential candidates for killing both actively growing and dormant Mycobacterium tuberculosis cells.

P2860

Q26824812-0309E0EF-416A-48A1-8348-7DA04E7594D1 Q26864729-EC84E68E-419B-4C13-89FF-683CE3C15E9E Q27316642-F74AE164-8B3D-4217-BC2F-004124C1BD5F Q27673316-80B99254-0CC1-492B-86A6-526ADB62DBBB Q27728459-4A8E68BA-C837-4505-BADC-68B1D440D94B Q28083600-95906763-4A21-4FC6-B412-75AEC46B6984 Q28533382-859C1313-A156-4EBB-AFCA-DB4EBC97E378 Q33798173-A1FFF31F-728B-40A4-BB9A-CD0E8FDE57EC Q33854785-6E3C0D8B-3A9C-41E3-8BA2-3425C58E85C0 Q33939074-0C1AB2B4-6269-4F75-9B6D-43C1CEDF7913 Q34461036-CD7D5D3B-A1F6-471E-B880-A253C0CC1293 Q34576222-A356A7F1-3A9D-4725-8B1E-81BB4918F2AD Q34596427-01CAB75D-35C3-44CD-88B6-D12F249DBF3B Q34784058-8C265DAE-05B3-4BCE-A457-94DAFC850E17 Q34881104-FC976C3A-C2BA-42CE-B1A0-5DB4BA04341C Q35243846-B0D56ED7-205A-4EC7-875E-4196EF0AE311 Q35670107-F35237F1-C825-47C8-9031-8EC95053E640 Q35842990-0E08B1DE-0228-4001-A537-1DBFA4996CAB Q36364079-D8228D10-C7B4-4747-8DE0-F97B8671B416 Q36449189-4ECB1771-CDC0-4FC1-B210-6D112AD02475 Q36740570-A8646EC8-0439-4078-9E6D-0EFFB89BBB1F Q37026681-194E83CB-D539-4E4B-B68E-C4F43EFA4C88 Q37101494-2E465CF2-AC7A-47A2-854B-ACE0E0403F96 Q37683485-B26EA0B9-C94B-410C-866F-A884DBC64F45 Q37713046-66C68224-6216-48AF-85B5-624B6E241630 Q37713071-57424D55-8585-4A0B-8CFB-7DE6A2B669CC Q37894691-7C1D9660-E2C0-4238-B053-ECBA2DC0B652 Q37926592-E8E125CC-4E2D-4164-BFB9-3D7DA19A3D1E Q37990720-C9344FE3-BD14-4D97-91C2-9DC1243E345F Q38014956-5759C218-B4F8-469B-A1DA-797FC2478332 Q38114535-CF153CCA-ED5D-44D0-B4A1-8C73BDE9C9C9 Q39015804-3DC306A9-D0C8-4DEA-8B7A-F5C4050A3167 Q39024963-A7A8A3C5-A4A8-4C1F-9A70-41E9F0FF3A6D Q39149038-3872271C-91E8-46C0-B0CB-1B63A7DD3E56 Q39345865-4D729DC1-5D17-40FD-992E-3FCED80E8BC1 Q39509772-5AFCA117-7A9A-46BB-82A3-FDEFDA187122 Q40474662-64A24F5B-64C7-4082-ADFC-0FC30B21863A Q41491201-32143FE5-080E-47B3-A476-D58146E16555 Q41569899-64484A0D-0197-415C-9081-830F4289DA86 Q41907472-8813FFCB-5786-4EF2-900B-68BE27C927FF

P2860

Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis

http://www.wikidata.org/entity/Q30496706

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis

@ast

Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis

@en

type

label

Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis

@ast

Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis

@en

prefLabel

Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis

@ast

Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis

@en

P1433

Q30496706-9BB95B5E-9EE2-4989-8D2E-FA184A52BDAD

P1476

Q30496706-20D37820-230C-4E28-9440-3DE88C96B8D1

P2093

Q30496706-5E1DC692-A553-4DF9-B91A-EEBAFC29F3BB

Q30496706-6C7DAE65-E22B-4A97-B6EE-D26EC8FD433D

Q30496706-B52BA95E-61E2-4755-ACB7-87580778D461

Q30496706-EAA9C543-FE6A-4A33-974E-80D342DF5A64

P2860

Q30496706-02CF54D2-9B1D-4D55-B9FA-406D952A47E1

Q30496706-042E5870-5EE8-409D-B607-26BB6A1C1213

Q30496706-0BB4C250-228C-4566-BD2B-3965AAF8BDBE

Q30496706-0EC0B879-0134-4944-8480-DAA721629E3F

Q30496706-139E2B42-9AC1-4FE9-834A-CDE4ACF27C6D

Q30496706-145A42F9-61FB-4E44-AB00-AA10A18FF858

Q30496706-1A9A16C5-8D4D-4CF0-8892-13BA31050C25

Q30496706-32CCE987-32D6-4CF4-B69C-0718377C7C12

Q30496706-36776959-997C-420F-9F6D-5E253C3E8C01

Q30496706-3749FB1D-39E0-452E-8233-B1574AADC138

P304

Q30496706-1FADEB76-002F-497E-B840-2D4C29478B09

P31

Q30496706-360180E6-FF1D-4129-A508-2AD4F87EE09D

P356

Q30496706-31C2C680-44CB-4E12-940C-88C37CC506D2

P407

Q30496706-941AE33D-D8CF-4D8B-8950-04DF65D7CFF8

P433

Q30496706-B5E07D56-3831-4F21-B425-D0C760B0946D

P478

Q30496706-364A9B83-E35D-4247-B0EC-E27E7EF125B4

P50

Q30496706-23CCF552-7BC5-4BF8-9533-5F3510F3276A

Q30496706-9C6CCE4C-2410-4228-9D90-3048D9C0D2ED

Q30496706-F5C14EFD-07F6-4CCA-B0DE-5A46824EE5FB

P577

Q30496706-CAD13948-B936-4747-8048-350F18F4641C

P698

Q30496706-4503681D-F11D-480A-86F6-CF06DB612F49

P921

Q30496706-990BE671-35DE-4C1F-AD11-C10D3723D882

P932

Q30496706-7FE125FB-8C83-493E-A986-713821E2FA71

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis

@en

P2093

Ming Zhang

http://www.w3.org/2001/XMLSchema#string

Patricia Schneider

http://www.w3.org/2001/XMLSchema#string

Stewart T Cole

http://www.w3.org/2001/XMLSchema#string

Young Hwan Ha

http://www.w3.org/2001/XMLSchema#string

P2860

PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence

A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis

Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes

Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling

P304

4150-4158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00821-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Ruben Hartkoorn

P577

2010-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20679505

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

2944619

http://www.w3.org/2001/XMLSchema#string